Breaks Categories: News

ThursdayNov 17, 2016 1:42 pm

NetworkNewsBreaks – Arkados Group, Inc. (AKDS) to Integrate Advanced Cellular Connectivity with Airfi Networks

Arkados Group (OTC: AKDS) this morning announced its agreement to integrate Airfi Networks’ advanced cellular connectivity solutions via SIMs, connected network and machine-to-machine (M2M) communication platform, into customer devices and systems that require around the clock communication, monitoring and data gathering. Arkados is a software developer and system integrator enabling Internet of Things ("IoT") applications. Now using Airfi, once a SIM is integrated into a system, the customers’ mobile devices will be able to establish communication between the system and the customers’ chosen central application servers using Airfi’s SIM and connected networks, and transmit data on the system almost immediately.…

Continue Reading

ThursdayNov 17, 2016 1:38 pm

NetworkNewsBreaks – Immune Pharmaceuticals (IMNP): $11 Million in New Financing Supports Bertilimumab Clinical Development

Immune Pharmaceuticals (NASDAQ: IMNP) is trading higher on news that it has secured up to $11 million in new financing from an existing single family office investor. The company continues to accumulate patients in two phase 2 clinical trials for its lead candidate bertilimumab for moderate-to-severe ulcerative colitis as well as for bullous pemphigoid, an orphan autoimmune dermatological condition. The company reports that in both conditions, a significant number of patients have elevated levels of eotaxin-1, considered a biomarker of disease severity. Targeting patients with elevated eotaxin-1 offers the potential to select patients who may be more likely to respond…

Continue Reading

ThursdayNov 17, 2016 11:54 am

NetworkNewsBreaks – Plug Power, Inc. (PLUG) Signs Deal for Fuel Cell Electric Vehicle Development in China

Plug Power (NASDAQ: PLUG) is trading higher after announcing its cooperative memorandum of understanding (MOU) with Zhangjiagang Furui Special Equipment Co., LTD (Furui), along with one of the “big three” Chinese industrial vehicle manufacturers. Per the agreement, the three companies will collaborate to build electric vehicles equipped with Plug Power-designed hydrogen fueling station solutions and hybrid fuel cell engine systems. The program is expected to deliver two industrial delivery truck prototypes by March of 2017, both powered by Plug Power’s ProGen fuel cell engines. The deal also calls for a short-term project for more than 500 vehicles and a fueling…

Continue Reading

WednesdayNov 16, 2016 12:54 pm

The Female Health Company (FHCO) Names New Marketing VP for Veru Healthcare

The Female Health Company (NASDAQ: FHCO) today announced the appointment of Shiao Zhu as vice president of marketing for Veru Healthcare and the manager of the Pharmaceuticals & Medical Devices and Consumer Health divisions of The Female Health Company. Shiao Zhu has a background in both marketing and sales, including new products, branded generics, drugs for uterine fibroids, hormone replacement therapy, IUDs, infertility, human papilloma virus, and 505(b)(2) products. “In the role of Vice President of Marketing, Shiao will leverage her considerable expertise in product commercial development and positioning in men’s and women’s health and oncology to lead the marketing…

Continue Reading

WednesdayNov 16, 2016 12:51 pm

MagneGas Corp. (MNGA) Announces $3M Placement; Shares Lower

Shares of MagneGas (NASDAQ: MNGA) are down more than 16% in mid-morning trade after the waste conversion company announced its agreement with a single institutional investor for a registered direct placement of approximately $3 million.  The Securities Purchase Agreement provides for the sale of $2.5 million of pre-funded warrants which are exercisable into 5,102,041 shares and $500,000 in payment for 1,020,408 shares. The placement is expected to close on or before November 18, 2016, subject to satisfaction of customary closing conditions. To view the full press release, visit: http://nnw.fm/4lMKN About MagneGas Corporation MagneGas® Corporation (MNGA) owns a patented process that converts…

Continue Reading

TuesdayNov 15, 2016 1:07 pm

Immunomedics, Inc. (IMMU) Receives 4 New Patents for Expanded Antibody-Drug Conjugate Program

Immunomedics (NASDAQ: IMMU) this morning announced it has received patent protection for the use of IMMU-132, the company’s lead antibody-drug conjugate (ADC) for the treatment of patients with Trop-2-positive cancers. Based on “encouraging objective response rates and durable responses” from an ongoing phase 2 clinical study, Immunomedics said it plans to expand its ADC program to include liquid tumors. As a result, the company created and received a patent for IMMU-140, as well as another ADC targeting B-cell hematologic malignancies. All three new ADC patents will expire in July 2033. Additionally, Immunomedics’ IBC Pharmaceuticals, Inc. subsidiary has received a patent…

Continue Reading

TuesdayNov 15, 2016 1:05 pm

Viking Therapeutics, Inc. (VKTX) Presents Additional Results of VK2809 for Treatment of High Cholesterol; Shares Higher

Viking Therapeutics (NASDAQ: VKTX) is trading higher after the clinical-stage biopharmaceutical company announced additional data from its previously completed phase 1b clinical trial designed to evaluate the safety and tolerability of VK2809 in subjects with mild hypercholesterolemia, or high cholesterol. As presented in a poster presentation earlier this week at the American Heart Association (AHA) Scientific Sessions 2016 in New Orleans, the new results show VK2809's effect on additional proteins associated with cardiovascular disease. "These data support the promise of thyroid beta-targeted approaches for the treatment of cardiovascular and other metabolic diseases.  We previously reported results showing VK2809's ability to…

Continue Reading

TuesdayNov 15, 2016 11:31 am

Moxian, Inc. (MOXC) Raises $10M in Public Offering, Uplists to NASDAQ

Moxian, Inc. (NASDAQ: MOXC) this morning made its debut on the NASDAQ Capital Market after a successful uplist from the OTCQB. The provider of an innovative offline-to-online (O2O) integrated social media platform also announced the completion of its public offering, for which it expects gross proceeds of about $10 million. To view the full press release, visit: http://nnw.fm/Rq2EN About Moxian, Inc. Moxian (MOXC) engages in the business of providing social marketing and promotion platforms to merchants who desire to promote their businesses through online social media. The company’s products and services aim to enhance the interaction between users and merchant…

Continue Reading

MondayNov 14, 2016 12:06 pm

Celldex Therapeutics (CLDX): CDX-1140 Data Shows Potential; Shares Climb

Shares of Celldex Therapeutics (NASDAQ: CLDX) are higher Monday morning after the company said it presented data on new product candidate CDX-1140, a fully human antibody targeted to CD40 that has demonstrated potent agonist activity. The data were presented over the weekend at the Society for Immunotherapy of Cancer Annual Meeting (SITC). Key findings include: CDX-1140 binds CD40 with high affinity and specificity and does not block CD40 ligand binding CDX-1140 has an unmodified IgG2 backbone and demonstrates potent agonist activity independent of Fc receptor interactions CDX-1140 demonstrates direct anti-tumor activity in immune-deficient mice challenged with human lymphomas Pharmacological activity…

Continue Reading

MondayNov 14, 2016 11:56 am

Acquisition Strategy Sets Medical Transcription Billing Corp. (MTBC) on Pace for Incremental Profits

Recently posting its fourth straight quarter of positive adjusted EBITDA and another quarter of YoY revenue growth, healthcare IT company Medical Transcription Billing, Corp. (NASDAQ: MTBC) (NASDAQ: MTBCP) is demonstrating increased momentum of its aggressive acquisition-based strategy.  The company most recently acquired Texas-based medical billing company MediGain, LLC, including substantially all of its assets and its subsidiary, for $7 million. “In total, the accounts in good standing acquired through this transaction have annual revenues in excess of $10 million … the MediGain acquisition is expected to be accretive to MTBC shareholders in 2017, as incremental profits are expected to greatly…

Continue Reading